Cargando…
Yeast oral vaccines against infectious diseases
Vaccines that are delivered orally have several advantages over their counterparts that are administered via injection. Despite the advantages of oral delivery, however, approved oral vaccines are currently limited either to diseases that affect the gastrointestinal tract or to pathogens that have a...
Autor principal: | Austriaco, Nicanor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149678/ https://www.ncbi.nlm.nih.gov/pubmed/37138614 http://dx.doi.org/10.3389/fmicb.2023.1150412 |
Ejemplares similares
-
Abstract 2150: Developing a COVID-19 Yeast Oral Vaccine for Low Income Countries
por: Bresnahan, Christopher, et al.
Publicado: (2023) -
Filamentation protects Candida albicans from
amphotericin B-induced programmed cell death via a mechanism involving the yeast
metacaspase, MCA1
por: Laprade, David J., et al.
Publicado: (2016) -
Endoplasmic reticulum involvement in yeast cell death
por: Austriaco, O. P., Nicanor
Publicado: (2012) -
Prudential Use of the Morally Controversial COVID-19 Vaccines
por: Austriaco, Nicanor Pier Giorgio
Publicado: (2021) -
Deletion of AIF1 but not of YCA1/MCA1 protects Saccharomyces cerevisiae and Candida albicans cells from caspofungin-induced programmed cell death
por: Chin, Christopher, et al.
Publicado: (2014)